Shizuoka, Japan

Shin-ichi Suzuki

This inventor holds 2 USPTO granted patents. Top assignees: The Lion Dentifrice Co., Ltd., The Lion Dentrifice Co., Ltd.. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin-ichi Suzuki. Retrieved from https://idiyas.com/inventor/shin-ichi-suzuki-ma3nu185

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 1980

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shin-ichi Suzuki

Introduction

Shin-ichi Suzuki is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential applications in cancer treatment. With a total of 2 patents, his work reflects a commitment to advancing medical science.

Latest Patents

One of his latest patents involves N-(2-Ethylhexyl)-crotonamides, which are novel compounds that effectively inhibit the growth of cancerous cells. These compounds are useful as carcinostatic agents, showcasing their potential in cancer therapy. Another significant patent is for 1-Phenyl-1H-pyrazolo[3,4-d]pyrimidine-4-carbonitrile, which includes derivatives that exhibit excellent anti-carcinogenic activities, as evidenced by animal tests with mice.

Career Highlights

Throughout his career, Shin-ichi Suzuki has worked with reputable companies such as Lion Dentrifice Co., Ltd. and Lion Dentifrice Co., Ltd. His experience in these organizations has contributed to his expertise in the field of chemical innovations.

Collaborations

Shin-ichi has collaborated with notable individuals in his field, including Akira Sakuma and Kenkichi Tomita. These partnerships have likely enhanced his research and development efforts.

Conclusion

Shin-ichi Suzuki's innovative work in developing compounds for cancer treatment highlights his significant contributions to medical science. His patents reflect a dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…